4-year overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001 Meeting Abstract
| Authors: | Felip, E.; Hellmann, M. D.; Hui, R.; Carcereny, E.; Leighl, N. B.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Aggarwal, C.; Horn, L.; Patnaik, A.; Gubens, M. A.; Ramalingam, S. S.; Jensen, E.; Kush, D. A.; Garon, E. B. |
| Abstract Title: | 4-year overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001 |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 467s |
| Language: | English |
| ACCESSION: | WOS:000442916003204 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9030 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9030 -- Source: Wos |
